Quartalszahlen: Evonik steigert operativen Gewinn und wird optimistischer
Evonik geht gestärkt in den Übernahmepoker mit BASF. Das Essener Chemieunternehmen hat am Dienstag positive Zahlen veröffentlicht. Dabei profitiert es von den Folgen des Iran-Kriegs.
Düsseldorf - Specialty chemicals firm Evonik, acquired by BASF, is reporting stronger financial performance and growing optimism about its future. The Essener firm is optimistic about its outlook for 2026, despite supply chain disruptions caused by the Middle East crisis. Interim CEO Claus Rettig emphasized the company's strength and resilience.
In the third quarter, Evonik's adjusted operational profit (EBITDA) rose by 40 percent to 629 million euros, the company reported on Tuesday. Revenue increased by 13 percent to 3.8 billion euros, beating analyst forecasts of 3.8 billion euros in revenue and 633 million euros in adjusted EBITDA. Special effects and cost-saving measures resulted in a loss of 53 million euros, compared to a loss of 106 million euros in the previous year's quarter.
Rettig is restructuring Evonik and cutting jobs to trim the company's costs. In their outlook for 2026, announced in June, the Essener were more confident, projecting a range between 2 and 2.2 billion euros for adjusted operational profit. BASF also benefited from higher prices and increased demand in the quarter due to the Middle East conflict.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
